title: Formulation and evaluation of mucoadhesive glipizide films.
abstract: Glipizide is mainly absorbed in the proximal areas of the gastrointestinal tract. The purpose of this study was formulation and evaluation of mucoadhesive films to prolong the stay of drug in its absorption area. Glipizide was formulated in a mucoadhesive film that could be retained in the stomach for prolonged intervals. Polymeric films were designed with various compositions of hydroxypropyl cellulose and polyethylene glycol 400 (PEG 400). Properties of the mucoadhesive film such as tensile strength, percentage elongation, swelling index, moisture content, pH and viscosity of polymeric dispersion, film thickness, content uniformity and mucoadhesion in a simulated gastric environment were characterized. In addition, percentage drug retained in stomach mucosa was estimated using a simulated dynamic stomach system as a function of time. Increase in hydroxypropyl cellulose concentration resulted in a higher tensile strength and elongation at break, while increase in concentration of PEG 400 was reflected in a decrease in tensile strength and increase of elongation at break. Glipizide/hydroxypropyl cellulose/PEG 400 (2.5:1:0.5) (GF5) was found to be the optimal composition for a novel mucoadhesive stomach formulation that showed good peelability, relatively high swelling index, moderate tensile strength, and stayed on rat stomach mucosa up to 8 h. In vivo testing of the mucoadhesive films with glipizide demonstrated a potential hypoglycemic effect.
authors.affiliation: Nootan Pharmacy College, S. P. Vidyadham, Visnagar-384315, India. ganesh_rajput83@yahoo.co.in
authors.forename: Ganesh
authors.initials: G
authors.lastname: Rajput
authors.forename: Falguni
authors.initials: F
authors.lastname: Majmudar
authors.forename: Jayvadan
authors.initials: J
authors.lastname: Patel
mesh_terms: D000268:Adhesiveness; D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D002482:Cellulose / Q000031:analogs & derivatives / Q000737:chemistry; D055598:Chemical Phenomena; D003692:Delayed-Action Preparations; D004337:Drug Carriers / Q000008:administration & dosage* / Q000737:chemistry* / Q000494:pharmacology; D004339:Drug Compounding; D005079:Excipients / Q000737:chemistry; D005260:Female; D005753:Gastric Mucosa / Q000378:metabolism*; D005913:Glipizide / Q000008:administration & dosage* / Q000737:chemistry* / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000737:chemistry* / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D055595:Mechanical Phenomena; D011092:Polyethylene Glycols / Q000737:chemistry; D011108:Polymers / Q000737:chemistry*; D051381:Rats; D017208:Rats, Wistar; D013047:Specific Pathogen-Free Organisms; D014867:Water / Q000032:analysis
chemical_list: D001786:Blood Glucose; D003692:Delayed-Action Preparations; D004337:Drug Carriers; D005079:Excipients; D007004:Hypoglycemic Agents; D011108:Polymers; D014867:Water; D011092:Polyethylene Glycols; D002482:Cellulose; C008079:hydroxypropylcellulose; D005913:Glipizide